Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond.

Toxins (Basel) · 2023 · PMC10535648 · PMID 37755957

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

While the CONTRAST study showed a decreasing trend in the use of ESA that did not reach a significant difference [ 14 ], the Turkish OL-HDF study showed a significantly lower weekly erythropoietin dose in patients undergoing HDF [ 15 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.